Compare TROW & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TROW | LH |
|---|---|---|
| Founded | 1937 | 1971 |
| Country | United States | United States |
| Employees | 4802 | 70000 |
| Industry | Investment Bankers/Brokers/Service | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.1B | 25.9B |
| IPO Year | 2000 | 2005 |
| Metric | TROW | LH |
|---|---|---|
| Price | $104.18 | $320.83 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 11 | 9 |
| Target Price | $98.00 | ★ $311.33 |
| AVG Volume (30 Days) | ★ 1.2M | 656.0K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | ★ 5.18% | 1.12% |
| EPS Growth | 0.98 | ★ 18.33 |
| EPS | 5.10 | ★ 6.99 |
| Revenue | $2,370,700,000.00 | ★ $13,951,700,000.00 |
| Revenue This Year | $5.48 | $8.26 |
| Revenue Next Year | $1.56 | $4.81 |
| P/E Ratio | ★ $20.16 | $46.17 |
| Revenue Growth | ★ 26.65 | 7.25 |
| 52 Week Low | $85.22 | $244.52 |
| 52 Week High | $122.00 | $341.80 |
| Indicator | TROW | LH |
|---|---|---|
| Relative Strength Index (RSI) | 30.80 | 49.83 |
| Support Level | $101.55 | $250.82 |
| Resistance Level | $107.09 | $341.80 |
| Average True Range (ATR) | 1.98 | 8.06 |
| MACD | -0.59 | -1.68 |
| Stochastic Oscillator | 22.24 | 49.52 |
T. Rowe Price provides asset management services for individual and institutional investors. It offers a broad range of no-load US and international stock, hybrid, bond, and money market funds. At the end of May 2026, the firm had $1.892 trillion in managed assets, composed of equity (49%), balanced (37%), fixed-income and money market (11%), and alternative (3%) offerings. Approximately two-thirds of managed assets are held in retirement-based accounts, which provide T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a US-based asset manager, deriving less than 10% of its AUM from overseas.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.